Literature DB >> 8204253

[Meningoencephalitis due to Rickettsia conorii. Etiopathological, clinical and diagnostic aspects].

A Marcos Dolado1, J Sánchez Portocarrero, R Jiménez Madridejo, J C Pontes Navarro, D García Urra.   

Abstract

Boutonneuse fever (BF) is usually considered to be a benign rickettsiosis. However, severe presentations, resembling Rocky Mountain spotted fever, have been reported. There are few neurological complications, except in serious forms of the disease. We present a case of meningoencephalitis in a male adult suffering from BF, and we review the clinical, etiopathogenic and diagnostic aspects among the cases previously reported. We conclude that BF encephalitis would have the following characteristics: a) they mostly affect elderly males; b) they cause altered consciousness level, headaches and low rate of meningeal signs; c) absence of "tâche noir"; d) cerebrospinal fluid with slight pleocytosis and/or increased level of proteins, and normal glucose values; e) computerized tomography without significative changes, and f) high rate of morbidity and mortality. We emphasize that we should consider BF in the differential diagnosis of our environmental encephalitis.

Entities:  

Mesh:

Year:  1994        PMID: 8204253

Source DB:  PubMed          Journal:  Neurologia        ISSN: 0213-4853            Impact factor:   3.109


  3 in total

Review 1.  Rickettsial infections of the central nervous system.

Authors:  Zuzana Sekeyová; Monika Danchenko; Peter Filipčík; Pierre Edouard Fournier
Journal:  PLoS Negl Trop Dis       Date:  2019-08-29

2.  Atypical Cogan's Syndrome.

Authors:  João Queirós; Sofia Maia; Mariana Seca; António Friande; Maria Araújo; Angelina Meireles
Journal:  Case Rep Ophthalmol Med       Date:  2013-04-04

3.  Mediterranean spotted fever: clinical and laboratory characteristics of 415 Sicilian children.

Authors:  Claudia Colomba; Laura Saporito; Valentina Frasca Polara; Raffaella Rubino; Lucina Titone
Journal:  BMC Infect Dis       Date:  2006-03-22       Impact factor: 3.090

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.